| Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo E Miyauchi, H Morita, S Tanabe Journal of dairy science 92 (6), 2400-2408, 2009 | 168 | 2009 |
| Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small‐cell lung cancer H Ono, N Motoi, H Nagano, E Miyauchi, M Ushijima, M Matsuura, ... Cancer medicine 3 (3), 632-642, 2014 | 167 | 2014 |
| Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas Y Tsukita, N Fujino, E Miyauchi, R Saito, F Fujishima, K Itakura, ... Molecular cancer 18, 1-6, 2019 | 70 | 2019 |
| Plasma or serum: which is preferable for mutation detection in liquid biopsy? F Pittella-Silva, YM Chin, HT Chan, S Nagayama, E Miyauchi, SK Low, ... Clinical Chemistry 66 (7), 946-957, 2020 | 58 | 2020 |
| Cell wall fraction of Enterococcus hirae ameliorates TNF‐α‐induced barrier impairment in the human epithelial tight junction E Miyauchi, H Morita, J Okuda, T Sashihara, M Shimizu, S Tanabe Letters in applied microbiology 46 (4), 469-476, 2008 | 54 | 2008 |
| Distinct characteristics of small cell lung cancer correlate with central or peripheral origin: subtyping based on location and expression of transcription factor TTF-1 E Miyauchi, N Motoi, H Ono, H Ninomiya, F Ohyanagi, M Nishio, ... Medicine 94 (51), e2324, 2015 | 44 | 2015 |
| Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab … G Saito, Y Oya, Y Taniguchi, H Kawachi, F Daichi, H Matsumoto, ... Lung Cancer 161, 86-93, 2021 | 41 | 2021 |
| Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer—data from a randomized Phase III study … E Miyauchi, A Inoue, K Kobayashi, M Maemondo, S Sugawara, S Oizumi, ... Japanese Journal of Clinical Oncology 45 (7), 670-676, 2015 | 41 | 2015 |
| Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR E Miyauchi, S Morita, A Nakamura, Y Hosomi, K Watanabe, S Ikeda, ... Journal of clinical oncology 40 (31), 3587-3592, 2022 | 35 | 2022 |
| Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations K Kudo, F Ohyanagi, A Horiike, E Miyauchi, N Yanagitani, R Hoshi, ... Lung Cancer 74 (3), 401-404, 2011 | 30 | 2011 |
| Relapsed myasthenia gravis after nivolumab treatment A Mitsune, S Yanagisawa, T Fukuhara, E Miyauchi, M Morita, M Ono, ... Internal Medicine 57 (13), 1893-1897, 2018 | 29 | 2018 |
| Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma Y Saito, G Nagae, N Motoi, E Miyauchi, H Ninomiya, H Uehara, M Mun, ... Cancer science 107 (3), 320-325, 2016 | 29 | 2016 |
| Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study Y Tsukita, T Yamamoto, H Mayahara, A Hata, Y Takeda, H Nakayama, ... Radiotherapy and Oncology 160, 266-272, 2021 | 28 | 2021 |
| Prognostic factors and efficacy of first‐line chemotherapy in patients with advanced thymic carcinoma: A retrospective analysis of 286 patients from NEJ023 study R Ko, T Shukuya, Y Okuma, K Tateishi, H Imai, S Iwasawa, E Miyauchi, ... The Oncologist 23 (10), 1210-1217, 2018 | 26 | 2018 |
| Successful osimertinib rechallenge in a patient with T790M-mutant non–small cell lung cancer after osimertinib-induced interstitial lung disease E Miyauchi, M Ichinose, A Inoue Journal of Thoracic Oncology 12 (5), e59-e61, 2017 | 25 | 2017 |
| Japanese lung cancer society guidelines for stage IV NSCLC with EGFR mutations K Ninomiya, S Teraoka, Y Zenke, H Kenmotsu, Y Nakamura, Y Okuma, ... JTO clinical and research reports 2 (1), 100107, 2021 | 24 | 2021 |
| CD45+CD326+ Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients K Ishizawa, M Yamanaka, Y Saiki, E Miyauchi, S Fukushige, T Akaishi, ... Clinical Cancer Research 25 (22), 6756-6763, 2019 | 20 | 2019 |
| TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients T Matsuda, E Miyauchi, YW Hsu, S Nagayama, K Kiyotani, M Zewde, ... Oncoimmunology 8 (6), e1588085, 2019 | 20 | 2019 |
| Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations E Miyauchi, T Matsuda, K Kiyotani, SK Low, YW Hsu, Y Tsukita, ... Cancer science 110 (3), 867-874, 2019 | 20 | 2019 |
| Phase II study of modified carboplatin plus weekly nab‐paclitaxel in elderly patients with non‐small cell lung cancer: North Japan Lung Cancer Study Group Trial 1301 E Miyauchi, A Inoue, K Usui, S Sugawara, M Maemondo, H Saito, Y Fujita, ... The Oncologist 22 (6), 640-e59, 2017 | 17 | 2017 |
